Bill Title: Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Passed) 2024-02-07 - signed chap.29 [A08502 Detail]

Text: Latest bill text (Introduced) [HTML]

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
Senate	Senate Floor Vote - Final Passage	2024-01-29	59	0	0	4	63	Passed	Link	View
Assembly	Assembly Floor Vote - Final Passage	2024-01-23	146	2	0	1	149	Passed	Link	View
Assembly	Assembly Ways And Means Committee: Favorable refer to committee Rules	2024-01-22	31	0	0	4	35	Passed	Link	View
Assembly	Assembly Rules Committee: Favorable	2024-01-22	26	0	0	5	31	Passed	Link	View
Assembly	Assembly Insurance Committee: Favorable refer to committee Ways and Means	2024-01-08	23	0	0	1	24	Passed	Link	View

Social Comments on NY A08502